Matthew Stebbins
About Matthew Stebbins
Matthew Stebbins is a Senior Principal Scientist at Bristol Myers Squibb in Seattle, Washington, with extensive experience in viral vector manufacturing and process development.
Title
Matthew Stebbins holds the position of Senior Principal Scientist at Bristol Myers Squibb in Seattle, Washington, United States. His role involves supervising a team specializing in end-to-end process development for AAV (Adeno-Associated Virus) manufacturing processes aimed at ex vivo gene delivery.
Professional Experience
Matthew Stebbins has an extensive career in the biopharmaceutical industry. He has been with Bristol Myers Squibb in several capacities: as a Scientist in Viral Vector Process Development (2019-2021), Principal Scientist (2021-2022), and currently as Senior Principal Scientist. Before joining Bristol Myers Squibb, he served as a Scientist at Fujifilm Cellular Dynamics (2017-2019) and held a Research and Early Development internship at Genentech in 2014. Matthew began his research career as a Graduate Research Assistant at the University of Wisconsin-Madison (2011-2017).
Education and Expertise
Matthew Stebbins earned his Doctor of Philosophy (PhD) in Chemical Engineering from the University of Wisconsin-Madison, where he researched lab protocols for iPSC-derived blood brain barrier models. Prior to that, he completed a Bachelor of Science (BS) in Chemical Engineering at Iowa State University. Matthew specializes in both upstream process development and downstream project management, with expertise in suspension cell culture, process characterization, and process control strategy.
Viral Vector Manufacturing Expertise
Matthew Stebbins has specialized knowledge in viral vector manufacturing, particularly involving AAV and lentivirus. His role at Bristol Myers Squibb involves leading a team of seven in developing end-to-end processes for AAV manufacturing aimed at ex vivo gene delivery. He has significant experience in upstream and downstream aspects of process development, showcasing an ability to manage comprehensive development projects.
iPSC Engineering Projects
During his tenure at Fujifilm Cellular Dynamics, Matthew led multiple induced pluripotent stem cell (iPSC) engineering projects. He successfully scaled iPSC-derived CAR-T cell differentiations into suspension bioreactors, demonstrating his capability in advancing complex cell engineering initiatives. His work in this field has contributed to significant advancements in the application of iPSC technologies.